Aldeyra Therapeutics Inc (ALDX)
3.95
-0.14
(-3.42%)
USD |
NASDAQ |
May 17, 16:00
3.95
0.00 (0.00%)
After-Hours: 20:00
Aldeyra Therapeutics Cash from Investing (Quarterly): -30.38M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -30.38M |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 30.00M |
| December 31, 2022 | 27.00M |
| September 30, 2022 | 19.02M |
| June 30, 2022 | -17.94M |
| March 31, 2022 | -58.03M |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | -0.0078M |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 5.50M |
| June 30, 2020 | 17.30M |
| March 31, 2020 | 6.224M |
| December 31, 2019 | -4.285M |
| September 30, 2019 | 5.676M |
| June 30, 2019 | 7.922M |
| March 31, 2019 | 9.164M |
| December 31, 2018 | -28.97M |
| September 30, 2018 | -0.0213M |
| Date | Value |
|---|---|
| June 30, 2018 | 0.8566M |
| March 31, 2018 | 4.802M |
| December 31, 2017 | -8.11M |
| September 30, 2017 | -3.628M |
| June 30, 2017 | 0.6485M |
| March 31, 2017 | 0.8915M |
| December 31, 2016 | 1.320M |
| September 30, 2016 | 0.5667M |
| June 30, 2016 | -2.103M |
| March 31, 2016 | -0.0092M |
| December 31, 2015 | -12.95M |
| September 30, 2015 | -0.0542M |
| June 30, 2015 | -0.0304M |
| March 31, 2015 | -0.0014M |
| December 31, 2014 | -0.008M |
| September 30, 2014 | -0.0061M |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | |
| March 31, 2013 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-58.03M
Minimum
Mar 2022
30.00M
Maximum
Mar 2023
0.3999M
Average
--
Median
Dec 2020
Cash from Investing (Quarterly) Benchmarks
| AbbVie Inc | -9.588B |
| United Therapeutics Corp | 735.30M |
| Heron Therapeutics Inc | 1.278M |
| Esperion Therapeutics Inc | -0.073M |
| FibroGen Inc | 51.28M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -9.973M |
| Cash from Financing (Quarterly) | 0.0182M |
| Free Cash Flow | -30.86M |
| Free Cash Flow Per Share (Quarterly) | -0.1678 |
| Free Cash Flow Yield | -13.22% |